Pattern recognition receptors of innate immunity and their application to tumor immunotherapy
Open Access
- 29 January 2010
- journal article
- review article
- Published by Wiley in Cancer Science
- Vol. 101 (2) , 313-320
Abstract
Dendritic cells (DC) begin maturation in response to complex stimuli consisting of antigens and pattern molecules (PAMP) for the activation of the immune system. Immune adjuvant usually contains PAMP. Infection represents one event that is capable of inducing such a complex set of stimuli. Recently, DC were subdivided into a number of subsets with distinct cell‐surface markers, with each subset displaying unique differential maturation in response to pattern molecules to induce various types of effector cells. In the present study, we review how pattern recognition molecules and adaptors in each DC subset drive immune effector cells and their effect in the stimulated DC. Although tumor cells harbor tumor‐associated antigens, they usually lack PAMP. Hence, we outline the properties of exogenously‐added PAMP in the modulation of raising tumor immunity. In addition, we describe the mechanism by which DC‐dependent natural killer activation is triggered for the induction of antitumor immunity. (Cancer Sci 2010; 101: 313–320)Keywords
This publication has 66 references indexed in Scilit:
- Identification of a polyI:C-inducible membrane protein that participates in dendritic cell–mediated natural killer cell activationJournal of Experimental Medicine, 2010
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvantJournal of Experimental Medicine, 2009
- The Janus face of dendritic cells in cancerOncogene, 2008
- How dying cells alert the immune system to dangerNature Reviews Immunology, 2008
- SINTBAD, a novel component of innate antiviral immunity, shares a TBK1‐binding domain with NAP1 and TANKThe EMBO Journal, 2007
- Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cellsProceedings of the National Academy of Sciences, 2007
- Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cellsJournal of Clinical Investigation, 2006
- Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon inductionNature, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signalingBiochemical and Biophysical Research Communications, 2002